Description
Background: Glioblastoma multiforme is a highly aggressive brain tumor with a poor prognosis, and advances in treatment have led to only marginal increases in overall survival.
Copyright Statement
Reuse Permissions
Download count: 0
Details
Contributors
- Lussier, Danielle (Author)
- Woolf, Eric (Author)
- Johnson, John (Author)
- Brooks, Kenneth S. (Author)
- Blattman, Joseph (Author)
- Scheck, Adrienne (Author)
- ASU Biodesign Center Immunotherapy, Vaccines and Virotherapy (Contributor)
- College of Liberal Arts and Sciences (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2016-05-13
Resource Type
Collections this item is in
Identifier
- Digital object identifier: 10.1186/s12885-016-2337-7
- Identifier TypeInternational standard serial numberIdentifier Value1471-2407
Note
- The electronic version of this article is the complete one and can be found online at: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2337-7, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Lussier, D. M., Woolf, E. C., Johnson, J. L., Brooks, K. S., Blattman, J. N., & Scheck, A. C. (2016). Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet. BMC Cancer, 16(1). doi:10.1186/s12885-016-2337-7